[1]杨泽宇,何小丽,唐焘,等.艾杜糖醛酸-2-硫酸酯酶与结直肠癌转移及预后的关系[J].第三军医大学学报,2019,41(17):1635-1641.
 YANG Zeyu,HE Xiaoli,TANG Tao,et al.Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer[J].J Third Mil Med Univ,2019,41(17):1635-1641.
点击复制

艾杜糖醛酸-2-硫酸酯酶与结直肠癌转移及预后的关系(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第17期
页码:
1635-1641
栏目:
基础医学
出版日期:
2019-09-15

文章信息/Info

Title:
Relationships of iduronic acid-2-sulfatase with metastasis and prognosis of colorectal cancer
作者:
杨泽宇何小丽唐焘王迪廖雪梅余时沧
400038 重庆,陆军军医大学(第三军医大学)第一附属医院:全军临床病理学研究所,西南癌症中心1,干细胞与再生医学科2
Author(s):
YANG Zeyu HE Xiaoli TANG Tao WANG Di LIAO Xuemei YU Shicang

1Institute of Pathology, Southwest Cancer Center, 2Department of Stem Cell and Regenerative Medicine, First Affiliated Hospital, Army Medical University (Third Military Medical University) , Chongqing, 400038, China

关键词:
艾杜糖醛酸-2-硫酸酯酶结直肠癌肿瘤转移生物信息学
Keywords:
iduronic acid-2-sulfatase colorectal cancer neoplasm metastasis bioinformatics
分类号:
R345; R730.7; R735.3
文献标志码:
A
摘要:

目的寻找与结直肠癌转移相关并具有预后预测意义的溶酶体分子。方法获取TCGA数据库结直肠癌数据集(Colon Adenocarcinoma TCGA-632)结直肠癌临床样本信息和基因转录组测序表达矩阵;通过基于LASSO(least absolute shrinkage and selection operator)算法的Logistic回归筛选与远处转移相关的溶酶体基因;进一步利用基于LASSO算法的COX回归模型,筛选与结直肠癌患者预后相关的基因,并选择回归系数最大的艾杜糖醛酸-2-硫酸酯酶(iduronic acid-2-sulfatase,IDS)进行研究;收集本院2007-2008年50例结直肠癌患者肿瘤组织标本进行免疫组织化学染色,分析组织中IDS表达量与转移及预后的关系。结果TCGA数据库分析显示:发生淋巴结转移的结直肠癌患者IDS mRNA相对表达量高于无淋巴结转移的患者(N0 vs  N1-2: -0.103±0.073 vs 0.303±0.123,P=0.003);发生远处转移的结直肠癌患者IDS mRNA相对表达量高于无远处转移的患者(M0 vs  M1: 0.017±0.071 vs 0.636±0.296,P=0.003);IDS高表达患者的预后较低表达患者不良(总体生存期:P=0.008;无病生存期:P=0.007);COX回归分析显示:IDS mRNA高表达是结直肠癌患者预后不良的独立预测因素(P=0.014,风险系数为2.651,95%CI:1.217~5.775);50例结直肠癌组织免疫组化分析显示:发生淋巴结转移的结直肠癌患者IDS mRNA相对表达量高于无淋巴结转移的患者(N0 vs N1-3: 27.324±0.698 vs 40.674±3.528,P=3.0×10-5);发生远处转移的结直肠癌患者IDS mRNA相对表达量高于无远处转移的患者(M0 vs M1: 27.941±0.952 vs 39.320±3.467,P=1.2×10-5);IDS高表达患者预后不良(P=7.2×10-5);COX回归分析显示:IDS高表达是预后不良的独立预测因素( P=0.008,风险系数为5.847,95%CI:1.585~21.568)。结论IDS高表达的结直肠癌患者转移发生率高、预后差,IDS可作为结直肠癌患者独立预后预测因子。

Abstract:

ObjectiveTo select lysosomal molecules related to metastasis and prognosis of colorectal cancer. MethodsThe clinical sample information and gene transcriptome sequencing expression matrix of colorectal cancer TCGA database (Colon Adenocarcinoma TCGA-632) were obtained. The lysosomal genes associated with distant metastasis were screened by least absolute shrinkage and selection operator (LASSO)-based logistic regression. Further the LASSO-based COX regression model was employed to screen the genes closely related to prognosis of colorectal cancer patients. Among those genes, the iduronic acid-2-sulfatase (IDS) was selected because of its largest regression coefficient. Then, 50 paraffin embedded colorectal cancer tissues harvested in our hospital from 2007 to 2008 were used for IDS immunohistochemistry staining. The relationships of IDS expression level in the tissues with metastasis and prognosis of colorectal cancer were analyzed. ResultsThe results of TCGA database analysis showed that the relative mRNA expression level of IDS was significantly higher in the colorectal cancer patients with lymph node metastasis than those without (N0 vs  N1-2: -0.103±0.073 vs 0.303±0.123, P=0.003), and was much higher in those with distant metastasis than those without (M0 vs M1: 0.017±0.071 vs 0.636±0.296, P=0.003); and the patients with high expression of IDS had poor prognosis (overall survival: P=0.008; disease-free survival: P=0.007). COX regression analysis indicated that the mRNA expression of IDS was an independent predictors of colorectal cancer prognosis (P=0.014, Hazard ratio=2.651, 95%CI: 1.217~5.775). The results of immunohistochemical analysis for the 50 cases showed that the expression of IDS was higher in colorectal cancer patients with lymph node metastasis than those without (N0 vs  N1-3: 27.324±0.698 vs 40.674±3.528, P=3.0×10-5), and was higher in those with distant metastasis than those without (M0 vs M1: 27.941±0.952 vs 39.320±3.467, P=1.2×10-5), and the patients with high IDS expression suggested poor prognosis (P=7.2×10-5). COX regression analysis also suggested that IDS expression was an independent predictor of colorectal cancer prognosis (P=0.008, Hazard ratio=5.847, 95%CI: 1.585~21.568). ConclusionThe colorectal cancer patients with high expression of IDS is associated with high risk of metastasis and poor prognosis. The molecule could be regarded as an independent predictor of colorectal cancer patients.

参考文献/References:

[1]BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI:10.3322/caac.21492.
[2]YU W Y, JIANG J F, XIE L L, et al. Mortality trends in colorectal cancer in China during 2000-2015: A joinpoint regression and age-period-cohort analysis[J]. Prev Chronic Dis, 2018, 15: E156. DOI:10.5888/pcd15.180329.
[3]DAVIDSON S M, VANDER HEIDEN M G. Critical functions of the lysosome in cancer biology[J]. Annu Rev Pharmacol Toxicol, 2017, 57: 481-507. DOI:10.1146/annurev-pharmtox-010715-103101.
[4]TOWERS C G, THORBURN A. Targeting the lysosome for cancer therapy[J]. Cancer Discov, 2017, 7(11): 1218-1220. DOI:10.1158/2159-8290.CD-17-0996.
[5]ZHOU W H, GONG L, WU Q C, et al. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2018, 37(1): 215. DOI:10.1186/s13046-018-0890-4.
[6]LIU H, MA Y, HE H W, et al. SPHK1 (sphingosine kinase 1) induces epithelial-mesenchymal transition by promoting the autophagy-linked lysosomal degradation of CDH1/E-cadherin in hepatoma cells[J]. Autophagy, 2017, 13(5): 900-913. DOI:10.1080/15548627.2017.1291479.
[7]ZHAO T, DING X C, YAN C, et al. Endothelial Rab7 GTPase mediates tumor growth and metastasis in lysosomal acid lipase-deficient mice[J]. J Biol Chem, 2017, 292(47): 19198-19208. DOI:10.1074/jbc.M116.773093.
[8]KUNDU S T, GRZESKOWIAK C L, FRADETTE J J, et al. TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins[J]. Nat Commun, 2018, 9(1): 2731. DOI:10.1038/s41467-018-05013-x.
[9]KIM S M, KIM Y, JEONG K, et al. Logistic LASSO regression for the diagnosis of breast cancer using clinical demographic data and the BI-RADS lexicon for ultrasonography[J]. Ultrasonography, 2018, 37(1): 36-42. DOI:10.14366/usg.16045.
[10]HOLMES R S. Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene[J]. 3 Biotech, 2017, 7(1): 22. DOI:10.1007/s13205-016-0595-3.
[11]SMITH C M, FINGER J H, HAYAMIZU T F, et al. The mouse gene expression database (GXD): 2014 update[J]. Nucleic Acids Res, 2014, 42(Database issue): D818-D824. DOI:10.1093/nar/gkt954.
[12]DA SILVA E M, STRUFALDI M W, ANDRIOLO R B, et al. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)[J]. Cochrane Database Syst Rev, 2016, 2: CD008185. DOI:10.1002/14651858.CD008185.pub4.
[13]MEDEIROS M G, FERREIRA T M, LEITE E L, et al. New pathway of heparan sulphate degradation. Iduronate sulphatase and N-sulphoglucosamine 6-sulphatase act on the polymer chain prior to depolymerisation by a N-sulpho-glucosaminidase and glycuronidases in the mollusc Tagelus gibbus[J]. Comp Biochem Phys B, 1998, 119(3): 539-547.
[14]PASQUALINI J R. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer[J]. Zentralbl Gynakol, 1997, 119(Suppl 2): 48-53.
[15]AHMED S, OWEN C P, JAMES K, et al. Review of estrone sulfatase and its inhibitors: An important new target against hormone dependent breast cancer[J]. Curr Med Chem, 2002, 9(2): 263-273.
[16]NAKAMURA Y, SUZUKI T, FUKUDA T, et al. Steroid sulfatase and estrogen sulfotransferase in human prostate cancer[J]. Prostate, 2006, 66(9): 1005-1012. DOI:10.1002/pros.20426.
[17]CHURA J C, BLOMQUIST C H, RYU H S, et al. Estrone sulfatase activity in patients with advanced ovarian cancer[J]. Gynecol Oncol, 2009, 112(1): 205-209. DOI:10.1016/j.ygyno.2008.08.037.
[18]SHAH R, SINGH J, SINGH D, et al. Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review[J]. Eur J Med Chem, 2016, 114: 170-190. DOI:10.1016/j.ejmech.2016.02.054.
[19]PUROHIT A, REED M J, MORRIS N C, et al. Regulation and inhibition of steroid sulfatase activity in breast cancer[J]. Ann N Y Acad Sci, 1996, 784: 40-49.
[20]WADE A N, ENGLER J R, TRAN V M, et al. Measuring sulfatase expression and invasion in glioblastoma[J]. Methods Mol Biol, 2015, 1229: 507-516. DOI:10.1007/978-1-4939-1714-3_39.
[21]PRINZ R D, WILLIS C M, VILORIA-PETIT A, et al. Elimination of breast tumor-associated chondroitin sulfate promotes metastasis[J]. Genet Mol Res, 2011, 10(4): 3901-3913. DOI:10.4238/2011.December.8.9.
[22]WILLIS C M, KLPPEL M. Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells[J]. PLoS ONE, 2014, 9(8): e103966. DOI:10.1371/journal.pone.0103966.
[23]TADEO I, GAMERO-SANDEMETRIO E, BERBEGALL A P, et al. 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors[J]. Histol Histopathol, 2018, 33(5): 487-495. DOI:10.14670/HH-11-947. 

相似文献/References:

[1]邵新宏,于游,张才全.miR-34a靶向调控NOTCH1基因对SW480细胞增殖的影响[J].第三军医大学学报,2012,34(22):2297.
 Shao Xinhong,Yu You,Zhang Caiquan.Inhibitory effects of miR-34a on NOTCH1 gene expression and SW480 cell proliferation[J].J Third Mil Med Univ,2012,34(17):2297.
[2]王祥峰,张连阳,何渝军,等.结直肠癌患者血清及粪便中热休克蛋白60检测的临床意义[J].第三军医大学学报,2007,29(13):1334.
 WANG Xiang-feng,ZHANG Lian-yang,HE Yu-jun,et al.Clinical significance of HSP60 in serum and stool of colorectal cancer patients[J].J Third Mil Med Univ,2007,29(17):1334.
[3]陈曦,黄悦,于彬,等.结直肠癌单克隆抗体的制备及生物学特性鉴定[J].第三军医大学学报,2007,29(10):896.
 CHEN Xi,HUANG Yue,YU Bin,et al.Preparing and identifying a monoclonal antibody against human colorectal carcinoma[J].J Third Mil Med Univ,2007,29(17):896.
[4]甘露,张超,曾冬竹,等.结直肠癌患者腹腔镜手术与开腹手术后并发症的风险因素分析[J].第三军医大学学报,2008,30(17):1668.
 GAN Lu,ZHANG Chao,ZENG Dong-zhu,et al.Laparoscopic-assisted versus open colorectal surgery: risk factor analysis for postoperative complications[J].J Third Mil Med Univ,2008,30(17):1668.
[5]赵菲,李世拥,于波,等.青年与老年结直肠癌临床病理特征的对比分析[J].第三军医大学学报,2007,29(06):544.
 ZHAO Fei,LI Shi-yong,YU Bo,et al.Comparative study on clinical pathological characteristics of young and old patients with colorectal cancer[J].J Third Mil Med Univ,2007,29(17):544.
[6]马千里,马华,陈曦,等.C-KIT蛋白在结直肠癌中的表达及临床意义[J].第三军医大学学报,2006,28(08):830.
[7]梁后杰,赵晓昕.结直肠癌肝转移新辅助化疗的共识与争议[J].第三军医大学学报,2009,31(01):26.
[8]马恒太,余佩武,葛海燕,等.体力活动对结直肠癌发病影响的重庆地区大样本病例-对照研究[J].第三军医大学学报,2005,27(22):2276.
[9]温玉婷,刘伟,杨爱军,等.IL-17和STAT3在结直肠癌组织中的表达及临床意义[J].第三军医大学学报,2011,33(17):1812.
 Wen Yuting,Liu Wei,Yang Aijun,et al.Expression of IL-17 and STAT3 in colorectal cancer tissue and its clinical significance[J].J Third Mil Med Univ,2011,33(17):1812.
[10]李靓,李洋,王继见.hTR反义寡核苷酸对结直肠癌SW480细胞的凋亡及凋亡诱导因子表达的影响[J].第三军医大学学报,2010,32(22):2400.
 Li Liang,Li Yang,Wang Jijian.Effect of hTR antisense oligodeoxynucleotide on apoptosis and expressions of apoptosis inducing factor in colon carcinoma cells SW480[J].J Third Mil Med Univ,2010,32(17):2400.

更新日期/Last Update: 2019-09-09